Role of cerebrospinal fluid biomarkers in clinical trials for Alzheimer's disease modifying therapies

Ju Hee Kang, Na Young Ryoo, Dong Wun Shin, John Q. Trojanowski, Leslie M. Shaw

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Role of cerebrospinal fluid biomarkers in clinical trials for Alzheimer's disease modifying therapies'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology